Table 1.
Longitudinal change of MetS states among participants over the study period
| States of MetS | Baseline | F1 | F2 | F3 | F4 | Change (%) | P* | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Count | % | Count | % | Count | % | Count | % | Count | % | |||
| No Component | 1604 | 12.5 | 672 | 5.2 | 917 | 7.1 | 1154 | 9.0 | 1248 | 9.7 | − 22.1 | < 0.0001 |
| Isolated Overweight/Obesity | 1360 | 10.6 | 927 | 7.2 | 1370 | 10.6 | 2462 | 19.1 | 2725 | 21.2 | 100.3 | |
| Isolated Hypertension | 106 | .8 | 38 | .3 | 72 | .6 | 67 | .5 | 139 | 1.1 | 31.1 | |
| Isolated Dyslipidemia | 3902 | 30.3 | 2872 | 22.3 | 2112 | 16.4 | 1037 | 8.0 | 705 | 5.5 | − 81.9 | |
| Isolated Hyperglycemia | 143 | 1.1 | 96 | .7 | 279 | 2.2 | 303 | 2.4 | 456 | 3.5 | 218.8 | |
| Obesity + Hypertension | 233 | 1.8 | 128 | 1.0 | 131 | 1.0 | 284 | 2.2 | 508 | 3.9 | 118.0 | |
| Obesity + Dyslipidemia | 3325 | 25.8 | 4864 | 37.8 | 3767 | 29.2 | 3002 | 23.3 | 2017 | 15.7 | −39.3 | |
| Obesity + Hyperglycemia | 190 | 1.5 | 183 | 1.4 | 379 | 2.9 | 978 | 7.6 | 1192 | 9.3 | 527.3 | |
| Hypertension + Dyslipidemia | 264 | 2.0 | 190 | 1.5 | 178 | 1.4 | 94 | .7 | 97 | .8 | − 63.2 | |
| Hypertension + Hyperglycemia | 26 | .2 | 22 | .2 | 79 | .6 | 50 | .4 | 118 | .9 | 353.8 | |
| Dyslipidemia + Hyperglycemia | 350 | 2.7 | 538 | 4.2 | 737 | 5.7 | 351 | 2.7 | 333 | 2.6 | −4.8 | |
| MS | 1379 | 10.7 | 2352 | 18.3 | 2861 | 22.2 | 3100 | 24.1 | 3344 | 26.0 | 142.4 | |
*Two-sided p-value significance level = 0.05, and Cochrane test